Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $545.12 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $222.84 | 2 | $0 (2024) |
| Lundbeck LLC | $119.61 | 6 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $85.13 | 4 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $60.46 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $35.50 | 2 | $0 (2023) |
| ABBVIE INC. | $21.58 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $433.40 | 12 | Neurocrine Biosciences, Inc. ($222.84) |
| 2023 | $111.72 | 6 | Lundbeck LLC ($40.79) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: PSYCHIATRY | ||||||
| 05/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $130.70 | General |
| Category: Neuropsychiatry | ||||||
| 05/16/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $22.28 | General |
| Category: PSYCHIATRY | ||||||
| 04/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.78 | General |
| Category: PSYCHIATRY | ||||||
| 04/10/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Neurology | ||||||
| 03/14/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Neurology | ||||||
| 03/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: PSYCHIATRY | ||||||
| 03/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $92.14 | General |
| Category: Neuropsychiatry | ||||||
| 02/07/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $24.41 | General |
| Category: PSYCHIATRY | ||||||
| 01/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.35 | General |
| Category: PSYCHIATRY | ||||||
| 01/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Central Nervous System | ||||||
| 11/20/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.28 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Central Nervous System | ||||||
| 10/11/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.51 | General |
| Category: PSYCHIATRY | ||||||
| 08/11/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 79 | 89 | $17,850 | $10,235 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 56 | 64 | $12,800 | $8,498 | 66.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 13 | $2,600 | $1,081 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $2,450 | $655.10 | 26.7% |
About Stacey Williams, FNP
Stacey Williams, FNP is a Clinical healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2010. The National Provider Identifier (NPI) number assigned to this provider is 1285951657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stacey Williams, FNP has received a total of $545.12 in payments from pharmaceutical and medical device companies, with $433.40 received in 2024. These payments were reported across 18 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($545.12).
As a Medicare-enrolled provider, Williams has provided services to 79 Medicare beneficiaries, totaling 89 services with total Medicare billing of $10,235. Data is available for 1 year (2023–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Clinical
- Other Specialties Family
- Location New York, NY
- Active Since 04/26/2010
- Last Updated 12/01/2023
- Taxonomy Code 1041C0700X
- Entity Type Individual
- NPI Number 1285951657
Products in Payments
- INGREZZA (Drug) $222.84
- REXULTI (Drug) $72.92
- CAPLYTA (Drug) $60.46
- UZEDY (Drug) $49.70
- ABILIFY ASIMTUFII (Drug) $46.69
- AREXVY (Drug) $35.50
- Austedo XR (Drug) $35.43
- VRAYLAR (Drug) $21.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Doctors in New York
Dr. Gerald Perlman, Ph.d, PH.D
Clinical
Dr. Gilbert Tunnell, Phd, PHD
Clinical
Rhona Lanzkowsky, Msw, MSW
Clinical
Dr. Robert Berger, Ph.d., Lcsw-R, PH.D., LCSW-R
Clinical
Mrs. Brigitte Lifschitz, Lcsw, LCSW
Clinical
Ms. Yelena Alperin, Lcsw, LCSW
Clinical